AbbVie’s upadacitinib meets primary endpoint in phase 2 SLE study
Based on the results of the mid-stage trial, the company is advancing the clinical programme of upadacitinib in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
24 Mar 23
Based on the results of the mid-stage trial, the company is advancing the clinical programme of upadacitinib in…
24 Mar 23
Presented at the American Academy of Dermatology (AAD) 2023 Annual Meeting, the FDA-submitted studies mark the first successful…
24 Mar 23
Christian Grosser goes on to emphasise a certain unique characteristic of MEDICA and COMPAMED which the over 5,000…
23 Mar 23
Kerecis is pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue…
23 Mar 23
The FDA approval extends Evkeeza’s indication to include children aged five to 11 years with homozygous familial hypercholesterolemia…
23 Mar 23
The approval was based on clinical data from the global ReSTORE phase 3 trial and is also backed…
21 Mar 23
"There was such incredible fan reaction following our first partnership with Minecraft, we had to bring it back…
21 Mar 23
As the first-ever compostable tea wrapper to be certified by the BPI, the packaging meets stringent standards for…
21 Mar 23
"We hope to inspire moments of everyday happiness with our newest innovation, DOVE Milk Chocolate Molten Lava Caramel…
21 Mar 23
"Easter has always been a special holiday for me, and now I love passing on the traditions I…